Eschborn, Germany
Summary
This company specializes in providing AI-driven solutions for drug discovery and development, utilizing a proprietary platform that integrates vast amounts of structured and unstructured data. Their services encompass all stages of a drug's life cycle, from early discovery to commercialization, and they leverage advanced technologies such as machine learning and blockchain to enhance healthcare outcomes. The company collaborates with pharmaceutical and biotech partners to resolve challenges in drug development and aims to transform healthcare through innovative data-driven insights.
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
13.2 years — Since Oct 2011
Web Hosting
Platform
E-Mail Provider
Google GSuite
NAICS Code
541715
SIC 4 Digit Code
8731
SIC 2 Digit Code
87
Industry
1. Pharmaceutical and Biotechnology
2. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Vendor
Source
Microsoft
TXT Record
Atlassian
TXT Record
TXT Record
Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2011 |
|
|
|
|
|
|
|
|
|
|
|
|
2012 |
|
|
|
|
|
|
|
|
|
|
|
|
2013 |
|
|
|
|
|
|
|
|
|
|
|
|
2014 |
|
|
|
|
|
|
|
|
|
|
|
|
2015 |
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
|
2017 |
|
|
|
|
|
|
|
|
|
|
|
|
2018 |
|
|
|
|
|
|
|
|
|
|
|
|
2019 |
|
|
|
|
|
|
|
|
|
|
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|